Any discussion of what a new technology might make possible has to distinguish two things: what has been demonstrated, and what is still being investigated. This distinction is especially important in medical research, where early findings can be scientifically meaningful without yet representing a clinical application. This piece is mostly about the second category: the questions that researchers are now trying to answer.
The Starting Point
The Abreu BTT 700 is cleared by the FDA for noninvasive skin temperature measurement at the Brain-Eyelid Thermal Regulatory Tunnel, an orbital structure in which a blood vessel is insulated by low-conductivity fat.
Research by Dr. Marc Abreu and others on this anatomical site suggests that temperature measured there may reflect aspects of the brain’s thermal activity. That scientific hypothesis is the basis for the research directions described below.
It is important to be precise about what that means. The device’s existing clearance relates to noninvasive temperature measurement. The broader questions around brain thermal activity, continuous monitoring, physiological patterns, and possible future applications remain areas of investigation.
In other words, the technology provides a way to collect a signal. Research is now focused on understanding what that signal may reveal, how consistent it is, and under what conditions it may become scientifically or clinically useful.
Continuous Data as a Research Tool
Physiological variables that are measured continuously tend to reveal patterns that intermittent sampling can miss.
Continuous glucose monitoring is one of the clearest recent examples. It did not change what glucose is, but it changed what could be observed about it. Instead of relying only on isolated measurements, researchers and clinicians gained access to trends, fluctuations, responses to meals, exercise, sleep, and other daily events.
Whether brain temperature behaves in a similarly informative way is unknown.
That is the research question.
A continuous temperature signal could potentially reveal patterns that would not be visible through occasional measurements, but that possibility needs to be tested rather than assumed. Doing so requires data collected over time, under controlled conditions, and across well-defined populations.
Researchers must determine which variations are meaningful, which are normal, and which may simply reflect individual or environmental differences.
Where the Research Is Directed
Current investigation focuses first on characterizing the signal itself.
That includes studying how it behaves across different states of activity, rest, and sleep; how stable or variable it is within the same person; how consistent it is between individuals; and how it responds to controlled thermal challenge.
These are foundational questions.
Before any physiological signal can support broader medical conclusions, researchers need to understand its baseline behavior, reproducibility, sources of variation, and relationship to other measurable physiological changes.
BTT Medical Institute is also conducting a clinical safety study of controlled hyperthermia in healthy adults.
The purpose of that study is specifically to assess safety and tolerability under controlled conditions. It is not designed to demonstrate efficacy in any disease or medical condition, and it does not test the therapy in patients.
That distinction matters because safety studies and efficacy studies answer different questions. Establishing that a procedure can be performed safely under defined conditions does not establish that it treats a disease, improves an outcome, or should be used therapeutically.
Those questions would require separate research.
What the Data Could Help Clarify
If continuous measurements prove reproducible and physiologically meaningful, they may give researchers a new way to study thermal regulation over time.
For example, investigators could examine whether recurring patterns appear during sleep, physical activity, recovery, environmental temperature changes, or other controlled physiological states.
At this stage, however, these possibilities should be understood as research directions rather than established uses.
The value of the work lies precisely in reducing uncertainty: determining what can be measured reliably, what patterns are real, and which hypotheses are supported or rejected by data.
A Note on Expectations
Research at this stage generates hypotheses and evidence. It does not automatically produce treatments.
A promising physiological signal may lead to new experiments, better measurement methods, or future clinical studies, but each of those steps requires independent validation.
Describing early-stage research as though it already represents a diagnostic or therapeutic capability would misrepresent both the work and its timeline.
The appropriate question today is therefore not what the technology can already treat, but what continuous, well-characterized thermal data may allow researchers to understand next.